Impact of Drug Shortages During the COVID-19 Pandemic

Start Course Now

Class A Credits: 1.0

Format: Video

Run time: 49 mins

Course Launch Date: 5/15/20

Course Expires: 5/14/21

Understand the causes and implications of current drug shortages and how they impact clinical practice, particularly for drugs needed in the critical care of ventilated COVID-19 patients.

*COVID-19 webinar series supported, in part, by an educational grant provided by Medtronic and Johnson & Johnson.

***If you previously attended a live webinar or session for CE credit, you are not eligible to receive additional credit for the replays.***

The American Association of Nurse Anesthetists is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.

AANA is an approved provider by the California Board of Registered Nursing, CEP #10862.

Post-Test Attempt Notice
A minimum passing score of 80% is required to pass this course. You have TWO opportunities to achieve a passing score. If you fail to achieve a passing score of 80%, you will not receive CE credit for this course.

Content Disclaimer:

The views, information, or opinions expressed within the videos and audio are solely those of the individuals involved and do not necessarily represent those of the American Association of Nurse Anesthetists.

Course content has been prepared by the presenter/developer, and each viewer agrees that the presenter/developer is solely responsible for the content and the accuracy thereof. The viewer agrees that the American Association of Nurse Anesthetists has no responsibility or liability for the accuracy or completeness of the content.

  • Describe the current state, causes, and future outlook of current drug shortages, particularly for anesthetic and sedation drugs.
  • Describe frontline provider experiences, clinical implications, and mitigation strategies for care of COVID-19 patients in light of the drug shortages.

Brian D. Barry Jr., PhD, CRNA, CAE, FAAN

Daniel Kistner, PharmD

David J. Margraf, PharmD, MS

Erin R. Fox, PharmD, BCPS, FASHP

Erin completed a Drug Information Specialty Residency after graduating from the University of Utah College of Pharmacy in 1999. She serves as secretary of the P&T Committee and residency program director for the PGY2 Medication-Use Safety & Policy residency. Areas of interest include drug shortages, medication use policy, drug information, evidence based medicine, and drug costs. Erin frequently serves as a media resource regarding drug shortages and drug prices.

Lorraine Jordan, PhD, CRNA, CAE, FAAN

Chief Advocacy Officer - AANA